Adicet Bio Inc (ACET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 24,990 | 9,730 |
| Gross Profit | N/A | N/A | N/A | 24,990 | 9,730 |
| Operating Expenses | 122,114 | 127,615 | 152,038 | 97,541 | 71,163 |
| Operating Income | -122,114 | -127,615 | -152,038 | -72,551 | -61,433 |
| Interest Expense | 36 | 4 | 25 | 80 | 176 |
| Other Income | 5,347 | 10,497 | 9,405 | 2,841 | -515 |
| Pre-tax Income | -116,803 | -117,122 | -142,658 | -69,790 | -62,124 |
| Income Tax | N/A | N/A | N/A | N/A | -125 |
| Net Income Continuous | -116,803 | -117,122 | -142,658 | -69,790 | -61,999 |
| Net Income | $-116,803 | $-117,122 | $-142,658 | $-69,790 | $-61,999 |
| EPS Basic Total Ops | -16.95 | -21.33 | -52.96 | -27.20 | -32.00 |
| EPS Basic Continuous Ops | -16.95 | -21.33 | -53.03 | -27.18 | -32.05 |
| EPS Diluted Total Ops | -16.95 | -21.33 | -52.96 | -27.20 | -32.00 |
| EPS Diluted Continuous Ops | -16.95 | -21.33 | -53.03 | -27.18 | -32.05 |
| EPS Diluted Before Non-Recurring Items | -16.95 | -21.28 | -45.76 | -27.20 | -32.00 |
| EBITDA(a) | $-119,783 | $-122,776 | $-126,448 | $-69,884 | $-59,710 |